Hints and tips:
...Ropes & GrayO: 7; L: 6; I: 7; Total: 20The firm advised online payments company Stripe in creating a fund for carbon dioxide removal technologies....
...However, the data is skewed by a few big outperformers such as Tesla, Etsy and L Brands, all of which are led by relatively youthful bosses....
...John Van Reenen, Ronald Coase School professor, LSE: It will not regain its size....
...In a recent piece for The Hollywood Reporter, Penn said his father had been blacklisted by “chicken hawks (among them Ronald Reagan)”....
...The move will exacerbate tensions over a lack of clarity in the terms and conditions of investment as Gabon prepares to launch a licensing round for the deep waters off its coast....
...Glenmark Pharma in licensing deal with Sanofi Glenmark Pharmaceuticals said on Monday its unit has entered into an agreement with Sanofi to grant a licence for the development and commercialisation of GBR...
...“So I thought I would put together a portfolio of S&P 500 stocks, with 85 per cent exposure, then used OEX [the S&P 100 index] positions as a hedge.”...
...After the closing bell, the S&P 500 was down 2.4 per cent at 1,173.60; the Dow Jones Industrial Average lost 2 per cent to 10,926.77 and the Nasdaq Composite was 3 per cent lower at 2,424.25....
...James P. Esposito, head of US investment grade bond syndication. Carl Faker Douglas L. Feagin, financial industries group investment banking, Hong Kong Luca D....
...James P. Esposito, head of US investment grade bond syndication. Carl Faker Douglas L. Feagin Luca D. Ferrari, investment banking, telecommunications. Mark B....
...ServicePower Technology was flat at 32p in spite of talk the software company was set to announce an IT licensing and consultancy deal with a company in the US insurance sector worth more than £1m....
...THE CREATIONISTS: From Scientific Creationism to Intelligent Design by Ronald L....
...And when you look at it from a profit pool standpoint on what the P&L impact could be, and the fact that we still believe there’s still a tremendous amount of unmet medical need within pure, core pharma,...
International Edition